Proteomic study on sodium selenite-induced apoptosis of human cervical cancer HeLa cells

Liping Fu1, Qiong Liu, Liming Shen

  • 1College of Life Sciences, Shenzhen University, Shenzhen 518060, China.

Insights

Sodium selenite induces cancer cell death by increasing oxidative stress and damaging mitochondria. This study used proteomics to identify proteins involved in selenite-induced apoptosis in HeLa cells, revealing potential for selenium in cervical cancer treatment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Sodium selenite demonstrates anticancer properties by inducing apoptosis.
  • The precise molecular mechanisms, particularly via proteomics, remain under-investigated.
  • Cervical cancer remains a significant global health concern requiring novel therapeutic strategies.

Purpose of the Study:

  • To investigate the proteomic changes in human cervical cancer HeLa cells treated with sodium selenite.
  • To elucidate the mechanism of selenite-induced apoptosis in HeLa cells.
  • To identify potential therapeutic targets for cervical cancer treatment using selenium.

Main Methods:

  • Cell viability was assessed using MTT assay and morphological observation.
  • Proteomic analysis involved two-dimensional gel electrophoresis (2DE), MALDI-TOF mass spectrometry, and Western blot.
  • Reactive oxygen species (ROS) generation and mitochondrial membrane potential were measured using flow cytometry and laser confocal microscopy.

Main Results:

  • Sodium selenite at concentrations above 10 μmol/L significantly inhibited HeLa cell viability, with 40 μmol/L identified as optimal for proteomic study.
  • Proteomic analysis identified 13 differentially expressed proteins, many associated with oxidative stress, including peroxiredoxins and superoxide dismutase.
  • Increased ROS generation and decreased mitochondrial membrane potential were observed in selenite-treated cells, correlating with the downregulation of antioxidative proteins.

Conclusions:

  • Sodium selenite induces apoptosis in HeLa cells through a reactive oxygen species (ROS)-mediated mitochondrial pathway.
  • The identified differentially expressed proteins provide insights into the cellular response to selenite treatment.
  • Selenium compounds show promise as a potential therapeutic agent for cervical cancer.

Related Concept Videos